• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性血管性水肿:综述。

Hereditary Angioedema: A Review.

机构信息

Division of Allergy/Clinical Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin,

出版信息

WMJ. 2022 Apr;121(1):48-53.

PMID:35442579
Abstract

Hereditary angioedema (HAE) is a rare and disabling disorder wherein there is excessive bradykinin production, with subsequent increased vascular permeability in the superficial tissues and gastrointestinal and respiratory mucosa. This article serves as a review of the pathogenesis of the disease, as well as an update of the evidence-based new treatment recommendations to help clinicians with the diagnosis and management of HAE.

摘要

遗传性血管性水肿(HAE)是一种罕见且使人丧失能力的疾病,其特征是缓激肽产生过多,随后导致浅表组织和胃肠道及呼吸道黏膜的血管通透性增加。本文旨在回顾该疾病的发病机制,并更新基于循证的新治疗建议,以帮助临床医生诊断和管理 HAE。

相似文献

1
Hereditary Angioedema: A Review.遗传性血管性水肿:综述。
WMJ. 2022 Apr;121(1):48-53.
2
Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.遗传性和获得性C1抑制物依赖性血管性水肿:从病理生理学到治疗
Ann Med. 2016;48(4):256-67. doi: 10.3109/07853890.2016.1162909. Epub 2016 Mar 26.
3
Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks.日本遗传性血管性水肿的管理:聚焦艾替班特治疗急性发作。
Allergol Int. 2021 Jan;70(1):45-54. doi: 10.1016/j.alit.2020.07.008. Epub 2020 Sep 9.
4
Hereditary Angioedema.遗传性血管性水肿。
Immunol Allergy Clin North Am. 2023 Aug;43(3):533-552. doi: 10.1016/j.iac.2022.10.012.
5
Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.遗传性 C1 抑制剂缺乏症所致血管性水肿的治疗管理循证推荐:国际工作组共识报告。
Allergy. 2012 Feb;67(2):147-57. doi: 10.1111/j.1398-9995.2011.02751.x. Epub 2011 Nov 30.
6
Hereditary and acquired angioedema.遗传性血管性水肿和获得性血管性水肿。
Allergy Asthma Proc. 2019 Nov 1;40(6):441-445. doi: 10.2500/aap.2019.40.4267.
7
Recognition, Evaluation, and Management of Pediatric Hereditary Angioedema.儿童遗传性血管性水肿的识别、评估和管理。
Pediatr Emerg Care. 2021 Apr 1;37(4):218-223. doi: 10.1097/PEC.0000000000002402.
8
Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.C1抑制剂水平正常的遗传性血管性水肿患者血浆中纤溶酶原激活物抑制剂2缺乏
J Allergy Clin Immunol. 2016 Jun;137(6):1822-1829.e1. doi: 10.1016/j.jaci.2015.07.041. Epub 2015 Sep 26.
9
Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment.C1抑制剂正常的遗传性血管性水肿:评估与治疗的最新进展
Immunol Allergy Clin North Am. 2017 Aug;37(3):571-584. doi: 10.1016/j.iac.2017.04.004.
10
Hereditary angioedema: Historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis.遗传性血管性水肿:历史方面、分类、病理生理学、临床表现和实验室诊断。
Allergy Asthma Proc. 2011 Jan-Feb;32(1):1-10. doi: 10.2500/aap.2011.32.3411.

引用本文的文献

1
Erratum: Effect of Fresh Frozen Plasma Infusion on Hospital Length of Stay for Patients With Hereditary Angioedema.勘误:新鲜冰冻血浆输注对遗传性血管性水肿患者住院时间的影响。
J Health Econ Outcomes Res. 2025 Aug 21;12(2):143440. eCollection 2025.
2
The adolescent experience of hereditary angioedema: a qualitative study of disease burden and treatment experience.青少年遗传性血管性水肿的经历:疾病负担与治疗体验的质性研究
Orphanet J Rare Dis. 2025 Jan 10;20(1):16. doi: 10.1186/s13023-025-03539-0.
3
Hereditary angioedema in children: Review and practical perspective for clinical management.
儿童遗传性血管性水肿:临床管理的综述与实践视角
Pediatr Allergy Immunol. 2024 Dec;35(12):e14268. doi: 10.1111/pai.14268.
4
Implications of Family-Oriented Psychotherapy for Hereditary Angioedema Management: A Case Series.以家庭为导向的心理治疗对遗传性血管性水肿管理的意义:病例系列
Cureus. 2024 Jul 27;16(7):e65526. doi: 10.7759/cureus.65526. eCollection 2024 Jul.
5
Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trial.在日本使用贝罗他司他进行遗传性血管性水肿的长期预防:随机APeX-J III期试验的第2部分和第3部分。
World Allergy Organ J. 2024 Mar 2;17(3):100882. doi: 10.1016/j.waojou.2024.100882. eCollection 2024 Mar.
6
Gluten Intolerance and Its Association With Skin Disorders: A Narrative Review.麸质不耐受及其与皮肤疾病的关联:一篇叙述性综述。
Cureus. 2023 Sep 1;15(9):e44549. doi: 10.7759/cureus.44549. eCollection 2023 Sep.
7
Real-world experience of hereditary angioedema (HAE) in Mexico: A mixed-methods approach to describe epidemiology, diagnosis, and treatment patterns.墨西哥遗传性血管性水肿(HAE)的真实世界经验:一种描述流行病学、诊断和治疗模式的混合方法。
World Allergy Organ J. 2023 Sep 13;16(9):100812. doi: 10.1016/j.waojou.2023.100812. eCollection 2023 Sep.
8
Neurologic and Psychiatric Manifestations of Bradykinin-Mediated Angioedema: Old and New Challenges.缓激肽介导的血管性水肿的神经和精神表现:旧的和新的挑战。
Int J Mol Sci. 2023 Jul 29;24(15):12184. doi: 10.3390/ijms241512184.
9
Factor XII Structure-Function Relationships.因子 XII 结构-功能关系。
Semin Thromb Hemost. 2024 Oct;50(7):937-952. doi: 10.1055/s-0043-1769509. Epub 2023 Jun 5.
10
Managing Diagnosis, Treatment, and Burden of Disease in Hereditary Angioedema Patients with Normal C1-Esterase Inhibitor.管理C1酯酶抑制剂水平正常的遗传性血管性水肿患者的诊断、治疗和疾病负担
J Asthma Allergy. 2023 Apr 22;16:447-460. doi: 10.2147/JAA.S398333. eCollection 2023.